Pacific Edge to stay in trading halt while legal team assesses proposal

Dan Brunskill
Fri, 29 Jul 2022

Pacific Edge will stay in a trading halt while its legal team looks at a draft proposal that could change whether its cancer test is eligible for health insurance funding. The company asked the exchange to stop trading this morning after it became aware its Cxbladder product was mentioned in a draft proposal from healthcare provider Novitas. Novitas provides government-sponsored healthcare in 11 US states and Washington DC, under the Medicare program.Cxbladder is currently eligible for reimbursement, meaning Novitas covers the cost of...

Not convinced yet?

Subscribe to our Daily News Update free newsletter.

Markets FREE
A2 shares plunge over FDA formula deferral
Staff reporters | Wed, 10 Aug 2022

A2 shares dropped 11% to $5.01 in early morning trading opened but made up a bit of lost ground by the end of the day.

Tourism
Tourism needs to 'embrace' job-sharing to spur recovery – report
Brent Melville | Wed, 10 Aug 2022

An industry that lost more than a third of its workforce during the pandemic needs to start thinking differently about work sharing.

Primary Sector
A2 Milk gets shot down because of issues in application
Rebecca Howard | Wed, 10 Aug 2022

The FDA continues to work around the clock to address current supply challenges, including reviewing a number of requests from manufacturers for enforcement discretion, as quickly as possible, a spokesperson said. 

Sponsored
A clearer path to the cloud

Step-by-step cloud transition can bring benefits, experts say.

Sponsored
Energy of the future: Why we need innovation

The Tomorrow’s Energy Today conference is looking at ways to develop a clean, affordable and reliable energy future, says Brendan Winitana, chair of the Sustainable Energy Association New Zealand (SEANZ).